Xanadu Bio, Inc. — Form D
Xanadu Bio, Inc. of GLADWYNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-27. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-08-27
- Form: D
- Accession: 0000929638-25-003261
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 4
- Date of first sale: 2025-08-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-555995
Issuer
- Name: Xanadu Bio, Inc.
- CIK: 0001946059
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 980 IDLEWILD ROAD, GLADWYNE, PA, 19035
- Phone: 610-937-6000
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Mark Saltzman | Director | Gladwyne, PA |
| Bruce Turner | Director | Gladwyne, PA |
| Todd Wider | Director | Dallas, TX |
| Taylor Feehley | Executive Officer | Gladwyne, PA |
| Bruce Turner | Executive Officer | Gladwyne, PA |
| Todd Wider | Executive Officer | Dallas, TX |
| Bruce Turner | Promoter | Gladwyne, PA |
| Todd Wider | Promoter | Dallas, TX |
Other filings by this issuer (1)
More